Practical implication
Implement increased documentation and reporting processes for traditional herbal medicinal products. Ensure staff receive training on the complexities involved in signal management for these products.
The European Medicines Agency has released a reflection paper focusing on safety signal management for traditional herbal medicinal products. Stakeholders are required to adapt their signal management workflows to address the unique challenges posed by the complexity of constituents in these products. There is a public consultation starting on July 15, 2026, with a deadline for comments set for October 15, 2026.
What changed: Stakeholders must adapt signal management workflows for herbal products to meet specific detection and assessment criteria as outlined in the reflection paper.
Why it matters: Improving safety signal detection and assessment for herbal medicinal products is crucial given their unique complexities, ultimately enhancing patient safety.
Practical implication: Implement increased documentation and reporting processes for traditional herbal medicinal products. Ensure staff receive training on the complexities involved in signal management for these products.
View original source
Published from the Firecrawl policy change extraction pipeline.
